The invention concerns compounds of formula (I), and their use in therapy, particularly in the modulation of CCR3 activity.

 
Web www.patentalert.com

< Indole, azaindole and related heterocyclic 4-alkenyl piperidine amides

> Nonnucleoside reverse transcriptase inhibitors
~ 00420